OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...
Bacteria are good at evolving to evade efforts to destroy it. But building defenses like antibiotic resistance drains limited ...
Bacteria can sneakily evade our best efforts at eradication by developing resistance to various pressures in their ...
New research links altered bile acids to chronic kidney disease progression, highlighting potential metabolic pathways ...
Bacteria can sneakily evade our best efforts at eradication by developing resistance to various pressures in their ...
Arthur Tzianabos, CEO, Lifordi Immunotherapeutics, spoke with PharmTech about the company’s immune-directed antibody-drug ...
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has ent ...
Ubiquitin is an abundant and ubiquitous protein in eukaryotes that is covalently attached to proteins, either as a tag for targeted protein degradation in the proteosome 1 or as a regulatory ...
Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...
Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges ...
Modern Engineering Marvels on MSN
Quantum breakthroughs hint at controlled time reversal in the lab
Would it be possible to control and even reverse the flow of time in a laboratory setting? While taking a trip back through ...
The research group of Professor Chuandong Dou at the State Key Laboratory of Supramolecular Structure and Materials, Jilin University, recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results